Biosergen AB
STO:BIOSGN
Cash Flow Statement
Cash Flow Statement
Biosergen AB
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
(47)
|
(27)
|
(27)
|
(29)
|
(27)
|
(24)
|
(19)
|
(17)
|
(22)
|
(30)
|
(39)
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
(18)
|
(5)
|
(18)
|
(3)
|
1
|
9
|
28
|
11
|
10
|
3
|
|
| Cash from Operating Activities |
(49)
N/A
|
(45)
+7%
|
(33)
+28%
|
(47)
-42%
|
(29)
+37%
|
(22)
+24%
|
(10)
+55%
|
10
N/A
|
(12)
N/A
|
(20)
-73%
|
(36)
-76%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
37
|
42
|
5
|
31
|
31
|
26
|
59
|
33
|
33
|
33
|
0
|
|
| Cash from Financing Activities |
37
N/A
|
42
+14%
|
5
-87%
|
31
+494%
|
31
N/A
|
26
-16%
|
59
+124%
|
33
-44%
|
33
N/A
|
33
N/A
|
0
N/A
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
|
| Net Change in Cash |
(12)
N/A
|
(3)
+74%
|
(27)
-801%
|
(15)
+45%
|
2
N/A
|
4
+86%
|
49
+1 171%
|
43
-12%
|
21
-51%
|
12
-42%
|
(36)
N/A
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(49)
N/A
|
(45)
+7%
|
(33)
+28%
|
(47)
-42%
|
(29)
+37%
|
(22)
+24%
|
(10)
+55%
|
10
N/A
|
(12)
N/A
|
(20)
-73%
|
(36)
-76%
|
|